Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03332953 · ClinicalTrials.gov registry record · NA

Sensory Perception of Sweet Flavors in E-Cigarette

A NA study of Smoking, sponsored by Oregon State University.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT03332953 is a NA study of Smoking that has completed, run by Oregon State University. The registered enrollment target is 19 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03332953, a NA study of Smoking, has completed, sponsored by Oregon State University.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

Despite the explosive popularity of sweet flavored electronic cigarettes, there is little empirical evidence regarding how "sweet" flavors interact with different levels of nicotine to reduce its perceived bitterness and harshness, and thereby increase its appeal and additive potential. This study will serve to fill this knowledge gap through empirical psychophysical data that will determine the association between sweet flavor and nicotine and its link to the acceptance and rejection of vaped nicotine.

Conditions Studied

Interventions

  • OTHER E-cigarettes with varying concentrations of nicotine & flavor

Study Locations (1)

Oregon

  • Oregon State University - Corvallis

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-01-21
Est. Completion 2018-06-12
Phase NA

Sponsor

Oregon State University

33 total trials

What the Registry Record Tells You About NCT03332953

The ClinicalTrials.gov registry entry for NCT03332953 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (96% lower). The listed sponsor is Oregon State University, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which E-cigarettes with varying concentrations of nicotine & flavor is the first listed.

NCT03332953 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT03332953 about?

NCT03332953 is a clinical study titled "Sensory Perception of Sweet Flavors in E-Cigarette". Despite the explosive popularity of sweet flavored electronic cigarettes, there is little empirical evidence regarding how "sweet" flavors interact with different levels of nicotine to reduce its perceived bitterness and harshness, and thereby increase its appeal and additive potential. This study w...

What is the current status of trial NCT03332953?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-01-21. Estimated completion is 2018-06-12.

What conditions does trial NCT03332953 study?

This clinical trial studies the following conditions: Smoking.

What interventions are being tested in trial NCT03332953?

The interventions under investigation include: E-cigarettes with varying concentrations of nicotine & flavor (OTHER).

Who is sponsoring clinical trial NCT03332953?

This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03332953 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.